Regulatory Challenges in Biotech
from Rx for Biotech Hosted by Podcast Host Chris Leidli
In this episode, Dr. Katie Graham reviews FDA regulatory review process for innovative new biotechnology and pharmaceutical products. Dr. Graham shares best practices in helping emerging biotechnology companies accelerate their organizational launch readiness.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Rx for Biotech?
This episode is 28 minutes long.
When was this Rx for Biotech episode published?
This episode was published on May 1, 2020.
Can I download this Rx for Biotech episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.